nifedipine

(redirected from Procardia xl)
Also found in: Dictionary, Thesaurus.
Related to Procardia xl: Calcium channel blockers, Nifedical XL

nifedipine

 [ni-fed´ĭ-pēn]
a calcium channel blocking agent administered orally as a coronary vasodilator in the treatment of angina pectoris; also used in the treatment of hypertension.

nifedipine

/ni·fed·i·pine/ (ni-fed´ĭ-pēn) a calcium channel blocking agent used as a coronary vasodilator in the treatment of coronary insufficiency and angina pectoris; also used in the treatment of hypertension.

nifedipine

(nī-fĕd′ə-pēn′)
n.
A calcium channel blocker drug, C17H18N2O6, that acts as a coronary vasodilator and is used primarily to treat hypertension and angina pectoris.

NIFEdipine

[nifed′ipēn]
a calcium channel blocker.
indications It is prescribed for the treatment of vasospastic and effort-associated angina, pulmonary hypertension, and hypertension (sustained-release form only).
contraindications Known hypersensitivity to this drug prohibits its use, and immediate-release forms should not be used to treat hypertension. The practice of using short-acting sublingual nifedipine in hypertensive emergencies or pseudoemergencies is dangerous and should be abandoned.
adverse effects Among the more serious adverse effects are hypotension, peripheral edema, palpitations, dyspnea, nausea, dizziness, flushing, and headache. When given sublingually, stroke, severe hypotension, syncope, heart block, sinus arrest, myocardial infarctions, and fetal distress are among the adverse effects reported.

nifedipine

Procardia® Cardiology A dihydropiridine CCB vasodilator used for angina, as a short-acting antihypertensive–↓ BP, resulting in a ↓ left ventricular volume and myocardial mass, ↑ ejection fraction Side effects Tachycardia, headache, peripheral edema, cerebral ischemia, stroke, severe hypotension, AMI, conduction defects, fetal distress, death. See Calcium channel blockers, Hypertension, TIBBS.

nifedipine

A CALCIUM CHANNEL BLOCKER drug used to control the symptoms of ANGINA PECTORIS and to treat high blood pressure (HYPERTENSION). It has a powerful effect in widening (dilating) arteries, including the coronary arteries, and this improves the blood supply to the heart muscle. The drug, however, causes flushing, headache, skin itching and dizziness. It is often used in combination with a BETA-BLOCKER. Nifedipine has been used effectively to prevent high altitude lung oedema, a feature of mountain sickness. The drug is on the WHO official list. Brand names are Adalat, Adipine MR, Angiopine MR, Cardilate MR, Coracten, Fortipine LA, Tensipine MR and Unipine XL.

nifedipine

calcium channel-blocking drug; may be used to treat severe perniosis, or to control pain of leiomyoma

nifedipine (nīfed´əpēn´),

n brand names: Procardia, Procardia XL;
drug class: calcium channel blocker;
action: inhibits calcium ion influx across cell membrane during cardiac depolarization; produces relaxation of coronary vascular smooth muscle, dilates coronary arteries; increases myocardial oxygen delivery in patients with vasospastic angina; dilates peripheral arteries;
uses: chronic stable angina pectoris, vasospastic angina, hypertension. Can cause gingival hyperplasia.

nifedipine

a calcium channel blocker used principally as a vasodilator.
References in periodicals archive ?
Biovail, through its marketing partner Teva Pharmaceuticals, is currently marketing generic versions of Adalat CC (30mg and 60mg) and Procardia XL (60mg) dosage strengths.
He supervised or was involved in the management of many successful clinical development programs for drugs including Procardia XL, Cardura, Zyrtec, Zoloft and Feldene.
Royalties in the second quarter of 2004 increased over the second quarter of 2003 primarily due to Mylan's stronger sales of generic Procardia XL in this year's quarter.
Procardia XL is a nifedipine product indicated for the treatment of hypertension and angina and had brand sales in excess of $522 million for the twelve months ended December 1999.
Royalties in the first quarter of 2004 increased over the first quarter of 2003 primarily due to Mylan's stronger sales of generic Procardia XL in this year's quarter.
Royalties increased in the fourth quarter of 2003 over the fourth quarter of 2002 primarily due to strong sales in the quarter by Mylan of generic Procardia XL.
it will begin selling generic forms of Pfizer's hypertension and angina drug Procardia XL.
Biovail Corporation International (NYSE:BVF) (TSE:BVF) announced today that it has exercised its option to purchase an exclusive license from Intelligent Polymers Limited for its generic version of Procardia XL for a purchase price of $25.